Cognitive behavioral therapy adds no value to drug treatment for opioid dependence

by Helen Dodson
Cognitive behavioral therapy adds no value to drug treatment for opioid dependence
Credit: Shutterstock

(Medical Xpress)—In a surprise finding, Yale researchers report that adding cognitive behavioral therapy to the most commonly used drug treatment for opioid dependence does not further reduce illicit drug use by patients. The study, which could change how such dependence is viewed and treated in the U.S. healthcare system, appears online in the American Journal of Medicine.

The medication, , has been in use for a decade, and is now prescribed to treat opioid dependence more than any other medication of its kind. Prescription by primary care and office-based physicians accounts for much of this increase. Cognitive behavioral therapy (CBT) is an intervention that has demonstrated effectiveness for many psychiatric conditions and substance use disorders, even beyond the period of treatment, but the impact of combining it with buprenorphine has not been clear until now.

To assess the impact, researchers conducted a involving 141 opioid-dependent patients in a primary care clinic. The patients were divided into two groups: those who received buprenorphine treatment alone under the care of a physician, and those who received the buprenorphine and professionally administered cognitive behavioral therapy.

The two treatments showed similar effectiveness – a significant reduction in self-reported frequency of opioid use. But the group receiving showed no more reduction in use than those receiving buprenorphine and physician care.

This finding contrasts with earlier studies that demonstrated improved outcomes with counseling services in patients receiving . But the Yale team notes that the key to success in the non-CBT group was that they were still under a primary physician's care while receiving buprenorphine – even if there was only a limited amount of counseling provided.

"This study demonstrates that some patients can do very well with buprenorphine and minimal physician support. This treatment represents an important tool to help reduce the adverse impact of addiction, HIV, and overdose due to heroin and prescription opioids," said lead author Dr. David A. Fiellin, professor of medicine, investigative medicine, and public health at Yale School of Medicine.

Related Stories

Suboxone is most effective in treating painkiller addiction

Nov 07, 2011

Individuals addicted to prescription painkillers are more likely to succeed in treatment with the aid of the medication buprenorphine-naloxone (Suboxone), report McLean Hospital and Harvard Medical School researchers in today's ...

Addicts helped by implanted devices: study

Oct 12, 2010

Persons addicted to heroin or prescription pain killers can get help kicking their habit by using an implanted device under the skin that delivers small doses of medication, researchers reported Tuesday.

Recommended for you

Social ties matter beyond bushfires

3 hours ago

In the first major release of findings from the Beyond Bushfires study of the aftermath of the Black Saturday bushfires, researchers from the University of Melbourne have been able to show the social element ...

Mom's prenatal hardship turns baby's genes on and off

4 hours ago

In January 1998 five days of freezing rain collapsed the electrical grid of the Canadian province of Québec. The storm left more than 3 million people without electricity for anywhere from a few hours to ...

Smoking rates high among people with psychotic illness

4 hours ago

The rate of smoking among people in Adelaide's northern suburbs who suffer from a psychotic illness is much greater than the national average and is contributing to other major health problems, according to new research from ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.